Literature DB >> 22493468

Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.

Ravi R Bajaj1, Ron Wald, Daniel G Hackam, Tara Gomes, Jeffrey Perl, David N Juurlink, Michael Manno, Amit X Garg, Abhijat Kitchlu, Muhammad M Mamdani, Andrew T Yan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22493468     DOI： 10.1001/archinternmed.2012.139

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  3 in total

1.  Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy.

Authors:  Manabu Hishida; Hirofumi Tamai; Takatoshi Morinaga; Michitaka Maekawa; Takafumi Aoki; Hidetaka Tomida; Shintaro Komatsu; Tomoaki Kamiya; Shoichi Maruyama; Seiichi Matsuo; Daijo Inaguma
Journal:  Clin Exp Nephrol       Date:  2016-02-23       Impact factor: 2.801

2.  Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis.

Authors:  Yoshiyuki Morishita; Eiji Kusano; Daisuke Nagata
Journal:  Open Cardiovasc Med J       Date:  2014-02-07

3.  The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis.

Authors:  Kuang-Ming Liao; Hui-Teng Cheng; Yi-Hsuan Lee; Chung-Yu Chen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.